Cipla launches generic drug Sofosbuvir in India
The drug will be sold under the brand name ‘Hepcvir'
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
HC bars Glenmark from selling anti-diabetes medicine
Anti-diabetes drugs, Zita and Zitamet, are set to go off the market in two weeks, with the Delhi High Court on Friday issuing an…
Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments
Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to…
Cadila Pharmaceuticals to observe World TB Day
The awareness campaign will highlight the importance of early diagnosis, regular dosage, completion of treatment and patient…
DRL in partnership with Hetero
To accelerate access to treatment for Hepatitis C in India
LIGHT AT THE END OF THE TUNNEL?
The launch of ‘2015 – Year of Active Pharmaceutical Ingredients’ could mark the beginning of a new chapter in the Indian pharma.…
The domestic underpinning of exports: Troubles in the world’s pharmacy
A perception has been built up that the ironically hyper-competitive Indian pharma sector is somehow earning windfall profits at…
Budget Blues
Positive budget, must ensure implementation and delivery
- Kiran Mazumdar Shaw, Chairperson, Biocon
FM’s speech was clear and…
Impact of IT on Indian pharma industry
Dr Subroto Ghoshal, Manager- Human Resources, Mindteck India elaborates on the need to improve connectivity between IT and pharma…
Growth hormone therapy market favours biobetters over biosimilars
GlobalData analyst states that long-acting GH biobetters will have an increased chance of market uptake upon entry